The coronavirus might have put pressure on many industries, the top healthcare companies in China do very well, says Rupert Hoogewerf, chief researcher of the Hurun Report in Laingbuissonnews.com. Healthcare is the third largest industry for non-state controlled companies in China, after manufacturing and real estate.
Laingbuissonnews.com
The average value of the Top 100 most valuable private healthcare companies in China is US$6.5bn, according to The Hurun Research Institute’s new “Hurun China 100 Most Valuable Private Healthcare Companies 2020” list.
The cut-off to make the list was US$2.1bn.
“Coronavirus has thrown the spotlight onto China’s top healthcare companies. Six companies from the Hurun Top 100 saw their share price up by half between January 20 and February 28, led by medical product business Allmed, which doubled in value, and followed by respiration equipment provider Yuyue, which rose 62%. Expect to see some of these companies continue to grow as the virus spreads around the world,” said Rupert Hoogewerf, chairman and chief researcher of Hurun Report.
He went on to explain that China’s top healthcare companies are now worth five times that of five years ago.
“China’s privately controlled healthcare companies are much more valuable than their state-controlled counterparts. The largest state-controlled healthcare business, TCM investment platform Changchun High & New Technology Industries, currently valued at US$13.8bn, would not have made the Top 10,” said Hoogewerf.
Healthcare is the third largest industry for non-state controlled companies in China, after manufacturing and real estate.
Rupert Hoogewerf is a speaker at the China Speakers Bureau. Do you need him at your meeting or conference? Do get in touch or fill in our speakers’ request form.
Are you looking for more strategy experts at the China Speakers Bureau? Do check out this list.
